JBIO

Jade Biosciences, Inc. Common Stock
JBIO

Overview Fund Activity

80 hedge funds and large institutions have $79.9M invested in Jade Biosciences, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 20 closing their positions.

Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
25
Reduced
13
Closed
20
Calls
$2.75M
Puts
$761K
Net Calls
+$1.99M
Net Calls Change
+$1.75M

Top Buyers

1
B
1
Braidwell
Connecticut
$3.82M
2
LGM
2
Logos Global Management
California
$3.71M
3
ACM
3
ADAR1 Capital Management
Texas
$2.46M
4
JFG
4
Jefferies Financial Group
New York
$1.59M
5
Blackstone Inc
5
Blackstone Inc
New York
$1.32M

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
BBA
2
Baker Bros. Advisors
New York
$0
3
EP
3
Eversept Partners
New York
$0
4
OCA
4
Octagon Capital Advisors
New York
$0
5
OM
5
Opaleye Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
DP
101
Diadema Partners
New Jersey
– – – –
CAL
102
Capital Advisors Ltd
Ohio
$0 8 – –
1 2 3 4
5